Price movement over the last 24 hours
ARK Genomic Revolution ETF vs ProShares Ultra Bloomberg Natural Gas ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while ProShares Ultra Bloomberg Natural Gas ETF trades at $21.94. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, ProShares Ultra Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | BOIL | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $43.57 | $98.62 |
52-Week Low | $23.09 | $22.68 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BOIL trades at $22.68, down 4.22% in the past 24 hours amid a bearish technical outlook with moving averages signaling strong selling pressure. The stock recently underwent a 1:2 split on May 28, 2026. Key support lies at $21, with resistance at $25. Recent news highlights shareholder meeting results and natural gas market volatility influencing sentiment.
Outlook remains cautious due to weak technicals and external commodity pressures. Investment opportunities hinge on natural gas price rebounds, but risks include sustained bearish trends and energy market fluctuations. Investors should weigh technical recovery signals against fundamental exposure to volatile energy sectors.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →BOIL is a leveraged ETF that seeks to provide two times (2x) the daily performance of the Bloomberg Natural Gas Subindex. It uses futures contracts to offer magnified exposure to natural gas price movements.
Read more on BOIL →